About: Nevi and melanomas

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Nevi and melanomas Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

medical condition

Attributes	Values
rdf:type	Item
owl:sameAs	Nevi and melanomas
description	medical condition (en) Krankheit (de) malattia (it) медичний стан (uk)
health specialty	wds:Q7004538-3AC3D7F7-7118-4296-8BD6-920B3869CB94
health specialty	oncology
rdfs:label	Nevi and melanomas (en) naevus et mélanomes (fr)
skos:prefLabel	Nevi and melanomas (en) naevus et mélanomes (fr)
name	Nevi and melanomas (en) naevus et mélanomes (fr)
instance of	wds:Q7004538-4D8A0ED6-1E72-43B1-88EF-05234245E9E5
instance of	disease
subclass of	wds:Q7004538-52908c50-4d6c-486a-6bb2-4e790a3519e9
subclass of	skin neoplasm
UMLS CUI	wds:Q7004538-14A03AF5-83BF-4444-94D6-6462D76B7235
MeSH descriptor ID	wds:Q7004538-01497cc3-4d52-1d99-b8ce-86ce16ffaa34
Microsoft Academic ID	wds:Q7004538-A8CD4CE7-67F7-4FB2-B0A4-E0741D587B4F
MeSH tree code	wds:Q7004538-2A3A9456-AFFE-45D8-9B2A-7D501E70E7C5
topic's main category	wds:Q7004538-21be985e-4b18-3dac-c7b1-6ac896a347b6
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D018326
Microsoft Academic ID	https://makg.org/entity/2775889082
MeSH tree code	http://id.nlm.nih.gov/mesh/C04.557.665
UMLS CUI	C0206769
MeSH descriptor ID	D018326
Microsoft Academic ID	2775889082
MeSH tree code	C04.557.665
topic's main category	Category:Melanocytic nevi and neoplasms
is about of	Nevi and melanomas https://www.wikidata.org/wiki/Special:EntityData/Q7004538 Nevi and melanomas
is cites work of	Primary malignant melanoma of the oral cavity in Indians
is cites work of	wds:Q43605364-FC63B5A8-A226-4C1A-86EA-717C090B984A
is medical condition of	Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) Using QPOP to Predict Treatment for Sarcomas and Melanomas Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors A Study of HX008 for the Treatment of Patients With Malignant Melanoma A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs A Retrospective Study on Laser Treatment of Nevus of Ota in Thai Patients Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors BO-112 With Pembrolizumab in Unresectable Malignant Melanoma Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab Melanoma Detection in Switzerland With VECTRA NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target? Uveal Melanoma and Brachytheraphy: Long-term Outcomes. Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) Study of the Nevisense Device to Assess Atypical Skin Lesions Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases Serial Tumour Biopsies and Blood Biomarkers in Melanoma The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma AI Augmented Training for Skin Specialists Community Based Strategies for Early Detection of Melanoma A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study A Prospective Natural History Study in Uveal Melanoma Neoadjuvant T-VEC in High Risk Early Melanoma Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1 Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases A Study of RC48-ADC in Advanced Melanoma Subjects With HER2-positive MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software